Cargando…
Targeted vs. systematic early antiviral treatment against A(H1N1)v influenza with neuraminidase inhibitors in patients with influenza-like symptoms: Clinical and economic impact
Capitalizing on available data, we used a decision model to estimate the clinical and economic outcomes associated with early initiation of treatment with neuraminidase inhibitors in all patients with influenza-like illnesses ( ILI ) (systematic strategy) vs. only those at high risk of complications...
Autores principales: | Deuffic-Burban, Sylvie, Lenne, Xavier, Dervaux, Benoit, Julien Poissy, Lemaire, Xavier, Sloan, Caroline, Carrat, Fabrice, Desenclos, Jean-Claude, Delfraissy, Jean-Francois, Yazdanpanah, Yazdan |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2768144/ https://www.ncbi.nlm.nih.gov/pubmed/20029659 http://dx.doi.org/10.1371/currents.RRN1121 |
Ejemplares similares
-
Molecular modeling of swine influenza A/H1N1, Spanish H1N1, and avian H5N1 flu N1 neuraminidases bound to Tamiflu and Relenza
por: Le, Ly, et al.
Publicado: (2011) -
The early diversification of influenza A/H1N1pdm
por: Nelson, Martha, et al.
Publicado: (2009) -
Seroprevalence Following the Second Wave of Pandemic 2009 H1N1 Influenza
por: Ross, Ted, et al.
Publicado: (2010) -
The Early Transmission Dynamics of H1N1pdm Influenza in the United Kingdom
por: Ghani, Azra, et al.
Publicado: (2010) -
The severity of pandemic H1N1 influenza in the United States, April – July 2009
por: Presanis, Anne M, et al.
Publicado: (2010)